|
All Immunology
Citations 81-90 of 276 total displayed.
|
Past content
(since Jan 2000):
|
- BRIEF COMMUNICATIONS
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
- Steven Vernino, Diva R. Salomao, Thomas M. Habermann, and Brian P. O’Neill
Neurology 2005; 65: 639-641.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Messenger RNA degradation may be inhibited in sporadic inclusion body myositis
- S. Nakano, A. Shinde, H. Ito, H. Ito, and H. Kusaka
Neurology 2005; 65: 420-425.
[Abstract]
[Full text]
[PDF]
- NEUROIMAGES
Large thalamic mass due to neuro-Behçet disease
- Heike Schmolck
Neurology 2005; 65: 436.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy
- R. Beekman, L. H. van den Berg, H. Franssen, L. H. Visser, J.T.H. van Asseldonk, and J. H.J. Wokke
Neurology 2005; 65: 305-307.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mechanical hyperalgesia in complex regional pain syndrome: A role for TNF- ?
- Christian Maihöfner, Hermann O. Handwerker, Bernhard Neundörfer, and Frank Birklein
Neurology 2005; 65: 311-313.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Neutralizing anti-IFN-ß antibodies: How much more evidence do we need to use them in practice?
- Gavin Giovannoni and Andrew Goodman
Neurology 2005; 65: 6-8.
[Full text]
[PDF]
- ARTICLES
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy
- P. Soelberg Sorensen, N. Koch-Henriksen, C. Ross, K. M. Clemmesen, K. Bendtzen, and the Danish Multiple Sclerosis Study Group
Neurology 2005; 65: 33-39.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Neutralizing antibodies and efficacy of interferon ß-1a: A 4-year controlled study
- L. Kappos, M. Clanet, M. Sandberg-Wollheim, E. W. Radue, H. P. Hartung, R. Hohlfeld, J. Xu, D. Bennett, A. Sandrock, S. Goelz, and the European Interferon Beta-1a IM Dose-Comparison Study Investigators
Neurology 2005; 65: 40-47.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Interferon ß-1a in MS: Results following development of neutralizing antibodies in PRISMS
- Gordon S. Francis, George P.A. Rice, Jonathan C. Alsop for the PRISMS (Prevention of Relapses and Disability by Interferon ß-1a Subcutaneously in Multiple Sclerosis) Study Group
Neurology 2005; 65: 48-55.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
High sensitivity measurement of CRP and disease progression in multiple sclerosis
- M. Soilu-Hänninen, J. O. Koskinen, M. Laaksonen, A. Hänninen, E. -M. Lilius, and M. Waris
Neurology 2005; 65: 153-155.
[Abstract]
[Full text]
[PDF]
|
|
